The VA does cover GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound, but coverage depends on the diagnosis being treated, the specific drug, and a prior authorization that a VA pharmacist must complete before the prescription is filled. None of these drugs are covered simply for weight loss without a qualifying medical condition, and the rules for enrolled veterans differ sharply from the rules that apply to family members under CHAMPVA.
Which GLP-1 Drugs the VA Stocks
Semaglutide injection sold as Ozempic, used for type 2 diabetes, sits on the national formulary with a “PA-F” designation. That means it is available, but each VA facility manages a prior authorization step locally. It falls in Copay Tier 2.1VA.gov. Semaglutide Injection Solution Formulary Advisor Tirzepatide (Mounjaro) carries the same PA-F status and is in Copay Tier 3.2VA.gov. Tirzepatide Injection Solution Formulary Advisor
Semaglutide for weight management, sold as Wegovy, is fully non-formulary. Prescribing it requires both a non-formulary drug request and prior approval. The VA’s Pharmacy Benefits Management office maintains a Wegovy criteria-for-use document dated April 2026 and broader weight-management prescribing recommendations dated March 2026.3VA.gov. Semaglutide (Wegovy) Injection Solution Formulary Advisor
Qualifying With Type 2 Diabetes
Veterans with type 2 diabetes can be prescribed a GLP-1 receptor agonist, particularly when they also have atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure. VA/DoD clinical guidelines recommend these drugs in high-risk patients regardless of whether blood sugar is already controlled, because the cardiovascular and renal benefits stand on their own.4U.S. Medicine. Increasing Prescribing of SGLT2is, GLP-1 RAs in High-Risk VA Diabetes Patients Clinicians generally try formulary options first, but they can move directly to a GLP-1 when a patient meets the clinical criteria.5U.S. Medicine. Determining What Weight Loss Medications Are Best for Veterans
Qualifying for Wegovy for Weight Management
The VA’s April 2026 criteria for Wegovy require two things at once. First, the veteran must have documented participation in a comprehensive lifestyle intervention covering diet, physical activity, and behavior change within the past year. Second, the veteran must have a BMI of 27 or higher along with at least one weight-related condition: hypertension, type 2 diabetes, prediabetes, dyslipidemia, obstructive sleep apnea, osteoarthritis, or metabolic dysfunction-associated liver disease.6VA Pharmacy Benefits Management. Criteria for Use: Semaglutide (Wegovy) for Weight Management Wegovy is also authorized to reduce secondary cardiovascular events in patients with overweight or obesity who have a history of heart attack, stroke, or symptomatic peripheral arterial disease.
Several groups are excluded. Patients who are pregnant or lactating, those with type 1 diabetes (unless supervised by a specialist), patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and patients with severe gastrointestinal dysmotility or a history of pancreatitis where the underlying cause still poses a risk are not eligible.6VA Pharmacy Benefits Management. Criteria for Use: Semaglutide (Wegovy) for Weight Management
The MOVE! Program Is Part of the Deal
The lifestyle-program requirement is not a formality. A VA patient brochure states that veterans prescribed weight management medication must “take part in a lifestyle change program (such as the MOVE! Program) that includes diet, physical activity, and behavioral counseling.”7VA Pharmacy Benefits Management. Weight Management Patient Brochure VA research has found that combining medication with MOVE! produces better weight-loss outcomes than medication alone.8Military.com. VA Clinic Gave Veterans GLP-1s for Weight Loss; a Year Later, Everything Improved The practical route is to ask your VA primary care provider for a MOVE! referral and start documenting participation before or alongside the medication request.
How Prior Authorization Actually Works
Because these drugs either require PA or sit off the formulary, your provider has to submit a request to the VA pharmacy with clinical documentation. For community care providers, the VA has published specific instructions: check the drug’s status on the VA Formulary Advisor, review the applicable criteria for use, and send the prescription with clinical notes, lab results, imaging, and a written justification that addresses each criterion.9VA Pharmacy Benefits Management. Community Care Network Provider Quick Reference
The VA pharmacy must complete its review within 96 hours of receiving the prescription. If approved, the medication is mailed to the veteran. If denied, a VA pharmacist contacts the prescriber to discuss alternatives and explain what would be needed to support a future request.9VA Pharmacy Benefits Management. Community Care Network Provider Quick Reference
What You Will Pay
Cost turns on your priority group and whether the medication treats a service-connected condition. Veterans in Priority Group 1, which includes those with a 50% or higher service-connected disability rating, pay no copays for any medication. Anything prescribed for a VA-rated service-connected condition is also copay-free, regardless of priority group.10VA.gov. VA Copay Rates
For veterans in priority groups 2 through 8 receiving a GLP-1 for a non-service-connected condition, 2026 copays apply by tier and days’ supply:
- Tier 2 (Ozempic): $8 for 30 days, $16 for 60 days, $24 for 90 days.
- Tier 3 (Wegovy, Mounjaro): $11 for 30 days, $22 for 60 days, $33 for 90 days.
All veterans are subject to a $700 annual cap on medication copays. Once you hit it, no further copays are charged that calendar year. VA weight-loss programs themselves carry no copay.10VA.gov. VA Copay Rates
CHAMPVA Rules Are Different
If you are asking about coverage for a spouse, surviving spouse, or dependent through CHAMPVA rather than for an enrolled veteran, the rules are tighter. Effective January 1, 2025, CHAMPVA explicitly excludes GLP-1 medications prescribed for weight loss.11VA.gov. Prescription Medications Covered Through Meds by Mail Coverage is limited to specific FDA-approved diagnoses paired with specific drugs:
- Type 2 diabetes: Mounjaro, Ozempic, Rybelsus, Trulicity, and Victoza.
- Obstructive sleep apnea: Zepbound, with a sleep study within the past 12 months.
- Metabolic-associated steatohepatitis or prevention of major adverse cardiovascular events: Wegovy.
Wegovy and Zepbound require prior authorization through OptumRx.12VA.gov. CHAMPVA Family Member Care Prescriptions for Ozempic or Mounjaro will not be filled for CHAMPVA beneficiaries without a type 2 diabetes diagnosis; prediabetes and obesity alone are not covered indications.13OptumRx. CHAMPVA Pharmacy Benefits
Supply Has Been a Real Constraint
Meeting the criteria has not always meant getting the drug. In late 2023, the VA stopped starting new patients on semaglutide during a global manufacturing shortage from Novo Nordisk. VA Press Secretary Terrence Hayes said “the low doses of Wegovy that are needed to titrate the patient to a therapeutic dose safely are not consistently available from the manufacturer.” Between September and November 2023, most VA facilities started no new veterans on Wegovy starter doses. Veterans already on the medication generally continued to receive it, while eligible new patients were referred to MOVE! for lifestyle management in the meantime.14Military.com. Vets Say Weight Loss Drugs Have Improved Their Health, but New Patients Are Out of Luck
Medicare and Tricare Decisions Do Not Change VA Coverage
The VA runs its own formulary. In April 2025 the Trump administration announced that Medicare would not cover GLP-1 drugs for weight loss, reversing an earlier Biden-era proposal; that decision does not apply to veterans using VA health care.8Military.com. VA Clinic Gave Veterans GLP-1s for Weight Loss; a Year Later, Everything Improved Tricare authorized coverage of weight-loss drugs for obesity starting in calendar year 2026, limited to Tricare Prime and Select beneficiaries with a prescription from a network provider and a comprehensive medical treatment plan.15Federal Register. TRICARE Notice of Plan Program Changes for Calendar Year 2026 Tricare For Life, which supplements Medicare for military retirees, does not cover weight-loss medications when obesity is the only diagnosis.16TRICARE Newsroom. Q&A: TRICARE for Life Coverage of Weight Loss Medications If you are enrolled in VA health care, the VA’s own criteria are what determine whether you can get a GLP-1.